Literature DB >> 16573297

Do adverse histopathologic findings in colorectal cancer patients explain disparate outcomes?

Keith D Gray1, Billy R Ballard, M Kay Washington, Rhonda Belue, William M Grady, William C Chapman, Steven C Stain.   

Abstract

We have previously reported reduced overall and disease-free survival in black patients from a 10-year retrospective review of 668 patients from tumor registry data. This study of 213 patients reports the analysis of available archived tissue from a city hospital (n=44 patients, 53% black) and from a university medical center (n=169, 10.6% black). Two senior pathologists independently reviewed slides for predetermined histologic criteria reported to correlate with survival: tumor type, stage at diagnosis, character of invasion, vascular or perineural invasion, the presence of residual adenoma, the presence of a Crohn's-like reaction and number of nodes resected. Differences in discrete variables were compared using the Chi-squared test. Differences in continuous variables were analyzed using independent t tests. No statistically significant differences were identified in tumor stage or type by institution or race. In patients treated at the city hospital, there was a higher incidence of infiltrating tumors (85% vs. 61%, p<0.001), vascular invasion (70% vs. 36%, p<0.05) and residual adenoma (84% vs. 39%, p<0.05); however, no differences by race were identified. Blacks at both hospitals had significantly more perineural invasion (81% vs. 30%, p<0.05) and Crohn's-like reaction (64% vs. 30%, p<0.05) when compared to white patients, although there was no difference between hospitals. The total number of lymph nodes resected was higher at the university hospital (17.0 vs. 8.9, p<0.001). There were no differences in number of nodes resected at either institution by race. Histopathologic findings did not explain the apparent disparity in survival. The differences in number of nodes harvested may suggest inadequate resection or insufficient recovery of nodes by the pathologist.

Entities:  

Mesh:

Year:  2006        PMID: 16573297      PMCID: PMC2576115     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  15 in total

1.  Race and outcomes: is this the end of the beginning for minority health research?

Authors:  O W Brawley; H P Freeman
Journal:  J Natl Cancer Inst       Date:  1999-11-17       Impact factor: 13.506

2.  THE GRADING AND PROGNOSIS OF CARCINOMA OF THE COLON AND RECTUM.

Authors:  R S Grinnell
Journal:  Ann Surg       Date:  1939-04       Impact factor: 12.969

3.  Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries.

Authors:  G S Cooper; Z Yuan; C S Landefeld; A A Rimm
Journal:  Am J Public Health       Date:  1996-04       Impact factor: 9.308

4.  Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival.

Authors:  L James Wudel; William C Chapman; Yu Shyr; Mark Davidson; Anita Jeyakumar; Selwyn O Rogers; Tara Allos; Steven C Stain
Journal:  Arch Surg       Date:  2002-05

5.  Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project.

Authors:  J J Dignam; L Colangelo; W Tian; J Jones; R Smith; D L Wickerham; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1999-11-17       Impact factor: 13.506

6.  Number of nodes examined and staging accuracy in colorectal carcinoma.

Authors:  J H Wong; R Severino; M B Honnebier; P Tom; T S Namiki
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

7.  Aggressiveness of colon carcinoma in blacks and whites. National Cancer Institute Black/White Cancer Survival Study Group.

Authors:  V W Chen; C M Fenoglio-Preiser; X C Wu; R J Coates; P Reynolds; D L Wickerham; P Andrews; C Hunter; G Stemmermann; J S Jackson; B K Edwards
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-12       Impact factor: 4.254

8.  Adverse histopathological findings as a guide to patient management after curative resection of node-positive colonic cancer.

Authors:  P H Chapuis; O F Dent; E L Bokey; R C Newland; G Sinclair
Journal:  Br J Surg       Date:  2004-03       Impact factor: 6.939

9.  Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator.

Authors:  D M Graham; H D Appelman
Journal:  Mod Pathol       Date:  1990-05       Impact factor: 7.842

10.  Peculiarities of mucinous colorectal carcinoma.

Authors:  H C Umpleby; D L Ranson; R C Williamson
Journal:  Br J Surg       Date:  1985-09       Impact factor: 6.939

View more
  5 in total

1.  Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans.

Authors:  Krishan Kumar; Hassan Brim; Francis Giardiello; Duane T Smoot; Mehdi Nouraie; Edward L Lee; Hassan Ashktorab
Journal:  Clin Cancer Res       Date:  2009-02-03       Impact factor: 12.531

2.  Impact of socioeconomic status on survival of colorectal cancer patients.

Authors:  Qian Zhang; Yufu Wang; Hanqing Hu; Rui Huang; Lei Xie; Enrui Liu; Ying-Gang Chen; Guiyu Wang; Xishan Wang
Journal:  Oncotarget       Date:  2017-09-13

3.  A National Study of Colorectal Cancer Survivorship Disparities: A Latent Class Analysis Using SEER (Surveillance, Epidemiology, and End Results) Registries.

Authors:  Francisco A Montiel Ishino; Emmanuel A Odame; Kevin Villalobos; Xiaohui Liu; Bonita Salmeron; Hadii Mamudu; Faustine Williams
Journal:  Front Public Health       Date:  2021-02-25

4.  Racial disparities in treatments and mortality among a large population-based cohort of older men and women with colorectal cancer.

Authors:  Xianglin L Du; Lulu Song
Journal:  Cancer Treat Res Commun       Date:  2022-08-06

5.  Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study.

Authors:  Hassan Brim; Pooneh Mokarram; Fakhraddin Naghibalhossaini; Mehdi Saberi-Firoozi; Mansour Al-Mandhari; Kamla Al-Mawaly; Rayhaneh Al-Mjeni; Abeer Al-Sayegh; Sandy Raeburn; Edward Lee; Francis Giardiello; Duane T Smoot; Alexander Vilkin; C Richard Boland; Ajay Goel; Mitra Hafezi; Mehdi Nouraie; Hassan Ashktorab
Journal:  Mol Cancer       Date:  2008-08-21       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.